--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 20.950
- -1.030-4.69%
Close Nov 15 16:00 ET
- 20.950
- 0.0000.00%
Post 20:01 ET
766.28MMarket Cap-10667P/E (TTM)
22.600High20.200Low86.76KVolume22.200Open21.980Pre Close1.80MTurnover0.94%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.37P/B192.74MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM10.92%Amplitude16.550Historical Low20.744Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
